Phase 3 study of Tolperisone in patients with acute, painful muscle spasms as well as for spasticity

Trial Profile

Phase 3 study of Tolperisone in patients with acute, painful muscle spasms as well as for spasticity

Planning
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2016

At a glance

  • Drugs Tolperisone (Primary)
  • Indications Muscle spasticity; Spasm
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Mar 2016 New trial record
    • 09 Mar 2016 According to Katama media release, there is an open investigational new drug application (IND) for Tolperisone and based upon the results of phase 2 and phase 3 trials a New Drug Application (NDA) may be filed within three years.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top